🇺🇸 FDA
Pipeline program

CG0070

CG2003C

Phase 2 mab completed

Quick answer

CG0070 for Non Muscle Invasive Bladder Cancer is a Phase 2 program (mab) at CG Oncology with 1 ClinicalTrials.gov record(s).

Program details

Company
CG Oncology
Indication
Non Muscle Invasive Bladder Cancer
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials